日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Clinical Role of the Adenoid Microbiome in the Development of Adenoid Hypertrophy and Otitis Media with Effusion

腺样体微生物群在腺样体肥大和渗出性中耳炎发生发展中的临床作用

Sokolovs-Karijs, Oļegs; Brīvība, Monta; Gudrā, Dita; Saksis, Rihards; Zodāne, Annija Alise; Rozenberga, Maija; Bunka, Laura; Frigotto, Anna; Osīte, Jana; Reinis, Aigars; Segliņa, Gunta; Krūmiņa, Angelika

Dual-approach analysis of gut microbiome in patients with type 1 diabetes and diabetic kidney disease

对1型糖尿病合并糖尿病肾病患者肠道微生物组进行双重分析

Bunka, Laura; Rozenberga, Maija; Silamiķelis, Ivars; Saksis, Rihards; Birzniece, Līga; Megnis, Kaspars; Fedulovs, Aleksejs; Pahirko, Leonora; Zaļizko, Poļina; Krustiņš, Eduards; Kloviņš, Jānis; Sokolovska, Jeļizaveta; Elbere, Ilze

Characterizing models for delivery of pharmacogenomic testing: a scoping review

药物基因组学检测交付模式的特征分析:范围界定综述

Waheed, Zeina; Bunka, Mary; Edwards, Louisa; Bousman, Chad; Hoens, Alison; Austin, Jehannine J; Bryan, Stirling

Comparing the Microbiome of the Adenoids in Children with Secretory Otitis Media and Children without Middle Ear Effusion

比较分泌性中耳炎患儿与无中耳积液患儿腺样体微生物群的差异

Sokolovs-Karijs, Oļegs; Brīvība, Monta; Saksis, Rihards; Rozenberga, Maija; Bunka, Laura; Girotto, Francesca; Osīte, Jana; Reinis, Aigars; Sumeraga, Gunta; Krūmiņa, Angelika

Relationship between pharmacotherapy for major depressive disorder and healthcare utilisation in British Columbia, Canada: a retrospective population-based cohort

加拿大不列颠哥伦比亚省重度抑郁症药物治疗与医疗保健利用的关系:一项基于人群的回顾性队列研究

Vijh, Rohit; Waheed, Zeina; Peterson, Sandra; Bunka, Mary; Pang, Nick; Edwards, Louisa; Ghanbarian, Shahzad; Wong, Gavin; Cressman, Sonya; Riches, Linda; Austin, Jehannine; Bryan, Stirling; Hoens, Alison; McGrail, Kimberlyn

A Canadian Simulation Model for Major Depressive Disorder: Study Protocol

加拿大重度抑郁症模拟模型:研究方案

Ghanbarian, Shahzad; Wong, Gavin W K; Bunka, Mary; Edwards, Louisa; Cressman, Sonya; Conte, Tania; Peterson, Sandra; Vijh, Rohit; Price, Morgan; Schuetz, Christian; Erickson, David; Riches, Linda; Landry, Ginny; McGrail, Kim; Austin, Jehannine; Bryan, Stirling

Cost-effectiveness of pharmacogenomic-guided treatment for major depression

药物基因组学指导治疗重度抑郁症的成本效益分析

Ghanbarian, Shahzad; Wong, Gavin W K; Bunka, Mary; Edwards, Louisa; Cressman, Sonya; Conte, Tania; Price, Morgan; Schuetz, Christian; Riches, Linda; Landry, Ginny; Erickson, David; McGrail, Kim; Peterson, Sandra; Vijh, Rohit; Hoens, Alison M; Austin, Jehannine; Bryan, Stirling

Highly Selective Aptamer-Molecularly Imprinted Polymer Hybrids for Recognition of SARS-CoV-2 Spike Protein Variants

用于识别SARS-CoV-2刺突蛋白变体的高选择性适体-分子印迹聚合物杂合物

Sullivan, Mark V; Allabush, Francia; Flynn, Harriet; Balansethupathy, Banushan; Reed, Joseph A; Barnes, Edward T; Robson, Callum; O'Hara, Phoebe; Milburn, Laura J; Bunka, David; Tolley, Arron; Mendes, Paula M; Tucker, James H R; Turner, Nicholas W

Costs of major depression covered / not covered in British Columbia, Canada

加拿大不列颠哥伦比亚省重度抑郁症的治疗费用是否在医保范围内

Cressman, Sonya; Ghanbarian, Shahzad; Edwards, Louisa; Peterson, Sandra; Bunka, Mary; Hoens, Alison M; Riches, Linda; Austin, Jehannine; Vijh, Rohit; McGrail, Kimberlyn; Bryan, Stirling

Collaborating with Patient Partners to Model Clinical Care Pathways in Major Depressive Disorder: The Benefits of Mixing Evidence and Lived Experience

与患者伙伴合作构建重度抑郁症临床护理路径模型:融合循证医学证据与亲身经历的益处

Bunka, Mary; Ghanbarian, Shahzad; Riches, Linda; Landry, Ginny; Edwards, Louisa; Hoens, Alison M; Bryan, Stirling